A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published in the journal Cell.
Compounds related to psychedelic drugs such as LSD and dimethyltryptamine (DMT) show great promise for treating disorders such as depression, post-traumatic stress disorder, and substance use disorder. These drugs are called psychoplastogens because of their ability to rapidly alter brain connections. But drugs that can cause hallucinations require very careful use and monitoring of patients.
Currently, the most effective way to test an experimental drug to see if it causes hallucinations is the "head twitch" assay in rodents.
"Scientific studies on psychedelic drugs have been conducted since the 1940s, but we still don't have an effective cellular assay for them," said a co-author on the paper.
The psychLight biosensor is based on the serotonin 2A receptor (HT2AR). Within the brain, serotonin released from neurons and picked up by serotonin receptors on other neurons acts to regulate mood. Both psychedelic drugs and drugs used to treat psychiatric disorders act through the serotonin 2A receptor.
The authors engineered a modified version of the HT2A receptor with a fluorescent component. When psychLight binds to serotonin or a hallucinogenic ligand it changes its conformation, causing the fluorescence to increase. Non-hallucinogenic ligands can also bind to psychLight but lead to a different fluorescence profile.
Researchers can use psychLight to see how naturally occurring neuromodulators like serotonin, or hallucinogenic drugs, act on different parts of the brain. They could also use it to screen candidate drugs for those which activate the HT2A receptor and could cause hallucinations. When psychLight is expressed in cells and those cell cultures are exposed to a hallucinogenic drug, they light up.
The sensor can be used to look for pharmaceutical potential without the side effect of hallucinations, the author said.
The researchers set up a high-throughput system to use cells expressing psychLight to screen compounds for hallucinogenic activity and for binding of the HT2A receptor. Using this, they showed that a previously untested compound, AAZ-A-154, activates the receptor but is not hallucinogenic. Subsequent tests in animal models confirmed that AAZ-A-154 shows promise as an antidepressant.
https://www.cell.com/cell/fulltext/S0092-8674(21)00374-3
Engineered biosensor, PsychLight inspired psychiatric drug discovery
- 1,474 views
- Added
Edited
Latest News
Targeting bone marrow adipo…
By newseditor
Posted 03 Jul
Mapping the biology of spin…
By newseditor
Posted 03 Jul
Liver biopsy to predict pan…
By newseditor
Posted 03 Jul
Significant differences in…
By newseditor
Posted 02 Jul
Serotonin 2C receptor regul…
By newseditor
Posted 02 Jul
Other Top Stories
Merged MRI and light sheet microscopy of the whole mouse brain
Read more
Identification of tunnels connecting neurons in the developing brain
Read more
Do people and monkeys see colors the same way?
Read more
Visualizing the disordered nuclear transport machinery in situ
Read more
Pre-association of β-arrestin with the plasma membrane drives coupl…
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Targeting adipocyte ESRRA p…
By newseditor
Posted 03 Jul
Stress-induced TDP-43 nucle…
By newseditor
Posted 03 Jul
Unraveling host regulation…
By newseditor
Posted 03 Jul
Propionic acid promotes neu…
By newseditor
Posted 03 Jul
Association of genetic risk…
By newseditor
Posted 03 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar